Navitas Life Sciences Announces Acquisition of KAI CRO

May 21, 2019

Applied Clinical Trials

Navitas Life Sciences announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc. KAI Research brings offerings in three key areas to the table – Clinical Trial Management, Clinical Research Consultation, and Data Management & Standardization.

For more details on the acquisition, click here.

Related Content:

News